11/15/2024
3:31 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
6:50 PM | Arcutis Biotherapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/13/2024
5:45 PM | Arcutis Biotherapeutics (Issuer)
Curran Terrie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
3:30 PM | Arcutis Biotherapeutics (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
11/12/2024
10:34 AM | Arcutis Biotherapeutics (Subject)
Curran Terrie (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
3:07 PM | Arcutis Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
3:41 PM | Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
11/01/2024
1:51 PM | Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
2:24 PM | Arcutis Biotherapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G/A | |
10/03/2024
3:55 PM | Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:55 PM | Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
2:32 PM | Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/25/2024
8:42 PM | Arcutis Biotherapeutics (Issuer)
Topper David Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
2:51 PM | Arcutis Biotherapeutics (Subject)
Topper David Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
4:56 PM | Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
12:37 PM | Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2024
3:39 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
4:43 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
3:45 PM | Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024
3:10 PM | Arcutis Biotherapeutics (Filer)
| Form 10-Q/A | |
07/02/2024
6:13 PM | Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
3:08 PM | Arcutis Biotherapeutics (Subject)
Smither John W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024
3:47 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2024
3:51 PM | Arcutis Biotherapeutics (Issuer)
CHAUDHURI BHASKAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:51 PM | Arcutis Biotherapeutics (Issuer)
Gilbert Halley E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:51 PM | Arcutis Biotherapeutics (Issuer)
LIN SUE-JEAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:51 PM | Arcutis Biotherapeutics (Issuer)
Krishnamohan Neha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:52 PM | Arcutis Biotherapeutics (Issuer)
Curran Terrie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:52 PM | Arcutis Biotherapeutics (Issuer)
Heron Patrick J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:52 PM | Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:52 PM | Arcutis Biotherapeutics (Issuer)
Leonard Keith R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
1:03 PM | Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
3:50 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
2:39 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
6:38 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
4:12 PM | Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
2:58 PM | Arcutis Biotherapeutics (Subject)
Edwards Larry Todd (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2024
3:08 PM | Arcutis Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
3:06 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
2:27 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024
2:28 PM | Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Let’s be blunt (Ad) Let me be blunt with you for just a second…
You may think you know when and why stocks move, but you’re wrong…
Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight.
But once you’ve cracked this code…
It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)!  Check out the $100 Challenge now |
05/02/2024
2:29 PM | Arcutis Biotherapeutics (Subject)
Moore Matthew Richard (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024
2:31 PM | Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/11/2024
7:30 PM | Arcutis Biotherapeutics (Issuer)
Topper David Joseph (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/11/2024
7:32 PM | Arcutis Biotherapeutics (Issuer)
Topper David Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:15 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:12 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:14 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:08 PM | Arcutis Biotherapeutics (Issuer)
Moore Matthew Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:09 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
11:40 AM | Arcutis Biotherapeutics (Subject)
Frazier Life Sciences VIII, L.P. (Filed by)
| Form SC 13D/A | |
03/06/2024
9:31 AM | Arcutis Biotherapeutics (Subject)
JENNISON ASSOCIATES LLC (Filed by)
| Form SC 13G/A | |
03/04/2024
4:44 PM | Arcutis Biotherapeutics (Subject)
OSBORNE DAVID W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
4:47 PM | Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
4:38 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
4:40 PM | Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
4:42 PM | Arcutis Biotherapeutics (Subject)
Moore Matthew Richard (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
3:21 PM | Arcutis Biotherapeutics (Filer)
| Form 424B5 | |
02/27/2024
3:34 PM | Arcutis Biotherapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024
6:48 AM | Arcutis Biotherapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2024
6:44 AM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
5:36 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:47 PM | Arcutis Biotherapeutics (Issuer)
Moore Matthew Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:23 PM | Arcutis Biotherapeutics (Issuer)
Smither John W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:30 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:32 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:19 PM | Arcutis Biotherapeutics (Subject)
| Form SC TO-I/A | |
02/15/2024
3:20 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
11:29 AM | Arcutis Biotherapeutics (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/13/2024
8:26 AM | Arcutis Biotherapeutics (Subject)
Polar Capital Holdings Plc (Filed by)
| Form SC 13G/A | |
02/12/2024
8:52 AM | Arcutis Biotherapeutics (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G | |
02/12/2024
5:06 AM | Arcutis Biotherapeutics (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G | |
02/08/2024
11:15 PM | Arcutis Biotherapeutics (Filer)
| Form EFFECT | |
02/08/2024
11:52 AM | Arcutis Biotherapeutics (Subject)
JENNISON ASSOCIATES LLC (Filed by)
| Form SC 13G | |
01/31/2024
4:22 PM | Arcutis Biotherapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/29/2024
2:26 PM | Arcutis Biotherapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G | |
01/23/2024
9:26 AM | Arcutis Biotherapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/17/2024
3:28 PM | Arcutis Biotherapeutics (Issuer)
Moore Matthew Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:30 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:32 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:34 PM | Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:35 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
5:03 AM | Arcutis Biotherapeutics (Subject)
| Form SC TO-I | |
01/03/2024
4:30 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
1:29 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
4:24 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
2:26 PM | Arcutis Biotherapeutics (Subject)
Turney Patricia A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023
5:33 AM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/01/2023
7:51 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
2:51 PM | Arcutis Biotherapeutics (Subject)
Burrows Scott L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
4:47 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Tesla Trade Is Back In Business (Ad) If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows…
But according to our one expert, new yearly highs are on the horizon…
In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker.
Which is why we’re emailing you now…
You see, most people will simply buy shares of Tesla ahead of the election…
But as they say “There is more than one way to skin a cat”
In fact, we’ve found another way to play shares of Tesla. Discover how to trade Tesla, simply follow this link here. |
11/21/2023
2:36 PM | Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
